Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06935747
PHASE4

Osteogenic Action of a Medical Device Based on Beta-tricalcium Phosphate (BTCP)

Sponsor: Mario Pérez Sayáns

View on ClinicalTrials.gov

Summary

The general objective of this split-mouth study is to analyze the osteogenic action of BTCP during the bone regeneration process following the extraction of impacted mandibular third molars.

Official title: Clinical Study to Analyze the Osteogenic Action of a Beta-tricalcium Phosphate-based Product in Bone Regeneration After the Extraction of Impacted Mandibular Third Molars.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2025-07

Completion Date

2026-07

Last Updated

2025-04-24

Healthy Volunteers

Yes

Interventions

COMBINATION_PRODUCT

Medical device: beta-tricalcium phosphate

The description of the intervention for BTCP in the study involves the application of this substance to promote bone regeneration following the extraction of impacted mandibular third molars. BTCP is indicated for the treatment of segmental and cavitary bone loss, aesthetic repairs, and bone augmentations (such as inlay or onlay grafts); for filling dental alveolar bone; for dental implant placement; and for the stabilization of osteotomies and prostheses in dentistry.

OTHER

Bovine Hydroxyapatite

The intervention description for Bio-Oss in the study involves the application of this standard material to promote bone regeneration following the extraction of impacted mandibular third molars. Bio-Oss is a commonly used xenograft material known for its osteoconductive properties.

Locations (2)

Universidade de Santiago de Compostela

Santiago de Compostela, A Coruña, Spain

University of Murcia

Murcia, Murcia, Spain